Devaraj Ezhilarasan-Devaraj
No.162, PH Road, 600 077
Chennai, TN, India
Chennai, TN, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
First Approval of Semaglutide for MASH in India: A Paradigm Shift in MASLD Management?
Journal: Drug discovery today
Published: July 28, 2026
Fibroblast growth factor 21 analogues in the FDA pipeline: Hope for metabolic dysfunction-associated steatotic liver disease therapy after resmetirom.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: April 04, 2026
Understanding regional differences in MASLD: the Indian perspective.
Journal: npj metabolic health and disease
Published: March 30, 2026
Silver diamine fluoride for dental caries: the good, the bad, and the ugly - insights from preclinical evidence.
Journal: Archives of oral biology
Published: January 12, 2026
Thioacetamide-induced hepatotoxicity in rats: Hepatoprotective role of ethyl gallate in association with the regulation of Nrf2/MAPK/NF-κB signaling pathway.
Journal: Toxicology and applied pharmacology
Published: January 02, 2026
Adulterated cough syrup caused acute kidney failure deaths in children: lessons have still not been learnt.
Journal: Regulatory toxicology and pharmacology : RTP
Published: October 24, 2025
Ethyl gallate attenuates 5-fluorouracil induced hepatic injury via MAPK/NF-κB downregulation in rats.
Journal: Toxicology and applied pharmacology
Published: October 22, 2025
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: October 16, 2025
Albendazole-induced liver injury in children: a cause for concern?
Journal: Drug discovery today
Published: January 06, 2025
SNRPE, an Oncofetal Protein: can be a Diagnostic Marker and Therapeutic Target for Oral Cancers?
Journal: Head and neck pathology
Published: September 17, 2024
Beyond resmetirom approval for NAFLD: what has to be done?
Journal: Drug discovery today
Published: September 02, 2024
Reply to "Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implications".
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: January 27, 2023
Last Updated: 09/26/2026